Literature DB >> 3669824

[Surgery of metastases of differentiated thyroid cancers].

H D Röher1, P E Goretzki, R A Wahl.   

Abstract

84 (19.5%) of 431 patients with differentiated thyroid cancer developed distant metastases in bone and parenchymal organs. 78% of primary bone metastases and only 21% of primary lung metastases were treated operatively. High survival rates of 33-60% at 5 years supported the necessity of surgical interventions primarily in bone metastases to prevent early morbidity due to pathological fractures. Even in case of questionable increase in survival rate surgery of metastases from differentiated thyroid carcinomas doubtlessly improves the quality of life in these patients.

Entities:  

Mesh:

Year:  1987        PMID: 3669824     DOI: 10.1007/bf01251902

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  21 in total

1.  99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma.

Authors:  A Miyauchi; K Endo; H Ohta; K Torizuka; F Matsuzuka; A Kobayashi; K Kuma; M Maeda
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 2.  The indications for ablating normal thyroid tissue with 131I in differentiated thyroid cancer.

Authors:  A W Goolden
Journal:  Clin Endocrinol (Oxf)       Date:  1985-07       Impact factor: 3.478

3.  Radiothallium scintigraphy in solitary nonfunctioning thyroid nodules.

Authors:  R Höschl; I P Murray; R G McLean; D Choy; J S Indyk
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

4.  External radiotherapy and radionuclide in the treatment of thyroid cancer.

Authors:  M Tubiana
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

5.  Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.

Authors:  M Schlumberger; M Tubiana; F De Vathaire; C Hill; P Gardet; J P Travagli; P Fragu; J Lumbroso; B Caillou; C Parmentier
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

6.  The encapsulated papillary carcinoma of the thyroid. A morphologic subtype of the papillary thyroid carcinoma.

Authors:  S Schröder; W Böcker; H Dralle; K B Kortmann; C Stern
Journal:  Cancer       Date:  1984-07-01       Impact factor: 6.860

7.  [Long-term observation of 15 patients with differentiated thyroid cancer and elevated plasma thyroglobulin levels of unclear origin].

Authors:  H P Stumpf; M Hüfner; H J Hermann; B Kimmig
Journal:  Klin Wochenschr       Date:  1984-05-02

8.  Vertebral body resection in the treatment of cancer involving the spine.

Authors:  N Sundaresan; J H Galicich; M S Bains; N Martini; E J Beattie
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

9.  Follicular carcinoma of the thyroid gland: trends and treatment.

Authors:  J K Harness; N W Thompson; M K McLeod; F E Eckhauser; R V Lloyd
Journal:  Surgery       Date:  1984-12       Impact factor: 3.982

10.  Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.

Authors:  N A Samaan; Y K Maheshwari; S Nader; C S Hill; P N Schultz; T P Haynie; R C Hickey; R L Clark; H Goepfert; M L Ibanez; C E Litton
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

View more
  1 in total

1.  European endocrine surgery in the 150-year history of Langenbeck's Archives of Surgery.

Authors:  Henning Dralle; A Machens
Journal:  Langenbecks Arch Surg       Date:  2010-03-09       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.